0001209191-22-037535.txt : 20220616
0001209191-22-037535.hdr.sgml : 20220616
20220616173548
ACCESSION NUMBER: 0001209191-22-037535
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220614
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Antal James
CENTRAL INDEX KEY: 0001315696
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38436
FILM NUMBER: 221021602
MAIL ADDRESS:
STREET 1: 30952 STEEPLECHASE DRIVE
CITY: SAN JUAN CAPISTRANO
STATE: CA
ZIP: 92675
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SIGA TECHNOLOGIES INC
CENTRAL INDEX KEY: 0001010086
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133864870
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 31 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 212-672-9100
MAIL ADDRESS:
STREET 1: 31 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10065
FORMER COMPANY:
FORMER CONFORMED NAME: SIGA PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19961108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-14
0
0001010086
SIGA TECHNOLOGIES INC
SIGA
0001315696
Antal James
C/O SIGA TECHNOLOGIES, INC.
31 EAST 62ND STREET
NEW YORK
NY
10065
1
0
0
0
Common Stock, par value $.0001 per share
2022-06-14
4
M
0
22831
A
123706
D
Common Stock, par value $.0001 per share
2022-06-14
4
D
0
6849
10.26
D
116857
D
Restricted Stock Units
2022-06-14
4
M
0
22831
0.00
D
Common Stock, par value $.0001 per share
22831
0
D
Restricted Stock Units
2022-06-14
4
A
0
14620
0.00
A
Common Stock, par value $.0001 per share
14620
14620
D
Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.
Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 17, 2021. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs.
The RSUs were granted on June 15, 2021, and fully vested on the date of the Company's 2022 annual meeting of stockholders.
RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 4,386 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors.
The RSUs fully vest on the date of the Company's 2023 annual meeting of stockholders.
/s/ James Antal
2022-06-15